Burkon P, Selingerova I, Vrzal M, Holanek M, Coufal O, Polachova K, Andraskova V, Jhawar SR, Slampa P, Kazda T, Slavik M. Quality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial. Sci Rep. 2025 Jan 9;15(1):1387. doi: 10.1038/s41598-025-85342-2.

Hrstka R, Zavadil-Kokas F, Moukova L, Kolarova T, Shahidianakbar M, Anton M, Ovesna P, Munzova D, Bednarikova M, Bretova P, Minar L, Hausnerova J, Weinberger V. Genetic analysis of uterine lavage fluids to identify women at high risk of endometrial cancer. BMC Res Notes. 2025 Mar 18;18(1):117. doi: 10.1186/s13104-025-07173-8.

Kacová R, Houfek T, Horký O, Kuráň J, Tomášik R, Růžička M, Hrstka R, Nováček V, Dudová Z. Integration, Cataloguing and Management of Biobanking and Clinical Data Using FAIR Genomes Metadata Schema. Data Intelligence. 2025;7(1):163-184. doi: 10.3724/2096-7004.di.2025.0005.

Moranova L, Strmiskova J, Ondraskova K, Bardelcik M, Cwik M, Kiss I, Hrstka R, Bartosik M. Electrochemical Detection of BRAF V600E Mutation in a Liquid Biopsy Format: LAMPing the Way to an Improved Diagnostics and Treatment. Adv Mater Technol. 2025;??:2401404. doi: 10.1002/admt.202401404. epub (IF2023: 6,4; Q1)

Němejcová K, Šafanda A, Kendall Bártů M, Hájková N, Drozenová J, Fabian P, Laco J, Matěj R, Méhes G, Škapa P, Stružinská I, Dundr P. HER2 Status in Low-grade Serous Ovarian Tumors. Int J Gynecol Pathol. 2025 Jul 30. doi: 10.1097/PGP.0000000000001059. Epub ahead of print. (1,6; Q3)

Němejcová K, Hájková N, Krkavcová E, Kendall Bártů M, Michálková R, Šafanda A, Švajdler M, Shatokhina T, Laco J, Matěj R, Hausnerová J, Škarda J, Náležinská M, Zima T, Dundr P. A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor. Virchows Arch. 2025 Nov 27. doi: 10.1007/s00428-024-03984-5. Epub ahead of print.

Pavlíčková K, Hojný J, Waldauf P, Dundr P, Hájková N, Švajdler M, Fabian P, Zambo IS, Flídrová M, Laco J, Hornychová H, Delongová P, Škarda J, Hrudka J, Matěj R. Correlation between p53 immunoexpression and TP53 mutation status in extrapulmonary small cell neuroendocrine carcinomas and its association with patient survival. Virchows Arch. 2025 Jan 23. doi: 10.1007/s00428-025-04024-6. Epub ahead of print.

Sebuyoya R, Sevcikova S, Yusuf B, Bartosik M. Integrating isothermal amplification techniques and LNA-based AI-assisted electrochemical bioassay for analysis of KRAS G12V point mutation. Talanta. 2025 Feb 7;288:127709. doi: 10.1016/j.talanta.2025.127709.

Seidler D, Winter L, Karlíková M, Topolčan O, Steiger K, Nováková K, Burkhardt R, Niedermair T, Brochhausen C. Bridging Financial Challenges in Young Biobanks-Funding Strategies from the Central Biobank Regensburg. Biopreserv Biobank. 2025 Dec 12. doi: 10.1089/bio.2023.0129. Epub ahead of print. (IF2023: 1,2; Q3)

Bartosik M, Moranova L, Izadi N, Strmiskova J, Sebuyoya R, Holcakova J, Hrstka R. Advanced technologies towards improved HPV diagnostics. J Med Virol. 2024 Feb;96(2):e29409. doi: 10.1002/jmv.29409. (IF2023: 6,8; Q1)

Benesova I, Nenutil R, Urminsky A, Lattova E, Uhrik L, Grell P, Kokas FZ, Halamkova J, Zdrahal Z, Vojtesek B, Novotny MV, Hernychova L. N-glycan profiling of tissue samples to aid breast cancer subtyping. Sci Rep. 2024 Jan 3;14(1):320. doi: 10.1038/s41598-023-51021-3. (IF2023: 3,8; Q1)

Bílek O, Selingerová I, Kysela M, Jedlička V, Kazda T, Berkovcová J, Turčáni P, Poprach A, Kiss I, Svoboda M, Zdražilová Dubská L. Aktuální klinické charakteristiky a léčebné postupy karcinomu plic v onkologickém centru v České republice z reálné praxe – data z registru Masarykova onkologického ústavu z let 2018–2022. Klin Onkol 2024;37(6):433-444. doi: 10.48095/ccko2024433. (IF2023: bez IF; Q4)

Burkon P, Selingerova I, Slavik M, Holanek M, Vrzal M, Coufal O, Polachova K, Muller P, Slampa P, Kazda T. Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study. Radiat Oncol. 2024 Feb 3;19(1):17. doi: 10.1186/s13014-024-02412-x. (IF2023: 3,3; Q1)

Fadrus J, Vybíhal V, Roskova I, Selingerová I, Smrcka M, Jancalek R, Šána J, Slabý O, Pospíšil P, Hynková L, Garčic J, Belanová R, Křístek J, Sprlakova-Pukova A, Mackerle Z, Juran V, Sova M, Neuman E, Valekova H, Lakomý R, Holánek M, Hrstka R, Svajdova M, Poláchová K, Kolouskova I, Šlampa P, Kazda T. Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice. Rep Pract Oncol Radiother. 2024;29(1):30-41. doi: 10.5603/rpor.99362. (IF2023: 1,2; Q3)

Hamala V, Ondrášková K, Červenková Šťastná L, Krčil A, Müllerová M, Kurfiřt M, Hiršová K, Holčáková J, Gyepes R, Císařová I, Bernášková J, Hrstka R, Karban J. Improving the anticancer activity of fluorinated glucosamine and galactosamine analogs by attachment of a ferrocene or ruthenium tetrazene motif. Appl Organomet Chem. 2024;38(5):e7399. doi: 10.1002/aoc.7399. (IF2023: 3,7; Q2)

Holikova K, Selingerova I, Pospisil P, Bulik M, Hynkova L, Kolouskova I, Hnidakova L, Burkon P, Slavik M, Sana J, Holecek T, Vanicek J, Slampa P, Jancalek R, Kazda T. Hippocampal subfield volumetric changes after radiotherapy for brain metastases. Neurooncol Adv. 2024 Mar 20;6(1):vdae040. doi: 10.1093/noajnl/vdae040. (IF2023: 3,7; Q1)

Izadi N, Strmiskova J, Anton M, Hausnerova J, Bartosik M. LAMP-based electrochemical platform for monitoring HPV genome integration at the mRNA level associated with higher risk of cervical cancer progression. J Med Virol. 2024 Oct;96(10):e70008. doi: 10.1002/jmv.70008. (IF2023: 6,8; Q1)

Jochmanová E, Nováková K, Růčková E, Hrstka R. České biobanky - zdroj kvalitního biologického materiálu. Florence 2014;20(2):84-86. (bez IF)

Kendall Bártů M, Němejcová K, Michálková R, Bui QH, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Matěj R, Méhes G, Šafanda A, Singh N, Škapa P, Špůrková Z, Stolnicu S, Švajdler M, Lax SF, McCluggage WG, Dundr P. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases. Int J Gynecol Pathol. 2024 Mar 1;43(2):123-133. doi: 10.1097/PGP.0000000000000962. (IF2023: 1,6; Q3)

Lapcik P, Synkova K, Janacova L, Bouchalova P, Potesil D, Nenutil R, Bouchal P. A hybrid DDA/DIA-PASEF based assay library for a deep proteotyping of triple-negative breast cancer. Sci Data. 2024 Jul 18;11(1):794. doi: 10.1038/s41597-024-03632-2. (IF2023: 5,8; Q1)

Peterka O, Maccelli A, Jirásko R, Vaňková Z, Idkowiak J, Hrstka R, Wolrab D, Holčapek M. HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer. Anal Chim Acta. 2024 Feb 1;1288:342144. doi: 10.1016/j.aca.2023.342144. (IF2023: 5,7; Q1)

Povedano E, Ruiz-Valdepeñas Montiel V, Sebuyoya R, Torrente-Rodríguez RM, Garranzo-Asensio M, Montero-Calle A, Pingarrón JM, Barderas R, Bartosik M, Campuzano S. Bringing to Light the Importance of the miRNA Methylome in Colorectal Cancer Prognosis Through Electrochemical Bioplatforms. Anal Chem. 2024 Feb 13;96(11):4580–4588. doi: 10.1021/acs.analchem.3c05474. (IF2023: 6,7; Q1)

Rihacek M, Wagnerova A, Halámková J, Paehalova L, Rihackova E, Boucek L, Kapounkova K, Hrnčiříková I, Kiss I. The impact of supervised and home exercise activity intervention on circulating immune cell numbers in cancer patients. Helyion. 2024;10(20):e39320. doi: 10.1016/j.heliyon.2024.e39320. (IF2023: 3,4; Q1).

Selingerova I, Holikova K, Chodur T, Hynkova L, Pospisil P, Bulik M, Belanova R, Siffelova K, Kolouskova I, Slavik M, Burkon P, Hrstka R, Jancalek R, Sana J, Slampa P, Kazda T. Challenges with hippocampal MR spectroscopy as a surrogate for pre-radiotherapy assessment of neurocognitive impairment in patients with brain metastasis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Apr 15. doi: 10.5507/bp.2024.012. Epub ahead of print. (IF2023: 0,7; Q4)

Stružinská I, Hájková N, Hojný J, Krkavcová E, Michálková R, Bui QH, Matěj R, Laco J, Drozenová J, Fabian P, Škapa P, Špůrková Z, Cibula D, Frühauf F, Jirásek T, Zima T, Méhes G, Kendall Bártů M, Němejcová K, Dundr P. Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas. J Mol Diagn. 2024 Apr;26(4):257-266. doi: 10.1016/j.jmoldx.2023.12.004. (IF2023: 3,4; Q1)

Vychytilova-Faltejskova P, Vilmanova S, Pifkova L, Catela Ivković T, Mᶏdrzyk M, Jugas R, Machackova T, Kotoucek J, Sachlova M, Bohovicova L, Stanek T, Halamkova J, Kiss I, Slaby O. Optimized procedure for high-throughput transcriptome profiling of small extracellular vesicles isolated from low volume serum samples. Clin Chem Lab Med. 2024 Jul 31;62(1):157-167. doi: 10.1515/cclm-2023-0610. (IF2023: 3,8; Q1)

Bohosova J, Kozelkova K, Al Tukmachi D, Trachtova K, Naar O, Ruckova M, Kolarikova E, Stanik M, Poprach A, Slaby O. Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma. J Cancer Res Clin Oncol. 2023 Aug;149(10):7587-7600. doi: 10.1007/s00432-023-04700-7. (IF2022: 3,6; Q2)

Gallo M, Krajňanský V, Nenutil R, Holub P, Brázdil B. Shedding Light on the Black Box of a Neural Network Used to Detect Prostate Cancer in Whole Slide Images by Occlusion-Based Explainability. N Biotechnol. 2023 Oct 2;78: 52-67. doi: 10.1016/j.nbt.2023.09.008. (IF2022: 5,4; Q1)

Grell P, Borilova S, Fabian P, Selingerova I, Novak D, Muller P, Kiss I, Vyzula R. FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer. Cancers (Basel). 2023 Mar 22;15(6):1901. doi: 10.3390/cancers15061901. (IF2022: 5,2; Q2)

Halámková J, Bohovicová L, Pehalová L, Kazda T, Goněc R, Staněk T, Mouková L, Adámková Krákorová D, Kozáková Š, Svoboda M, Demlová R, Gabrielová L, Hernychová L, Kiss I. The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers. Sci Rep. 2023 Mar 1;13(1):3490. doi: 10.1038/s41598-023-29535-7. (IF2022: 4,6; Q2)

Holub P, Müller H, Bíl T, Pireddu L, Plass M, Prasser F, Schlünder I, Zatloukal K, Nenutil R, Brázdil T. Privacy risks of whole-slide image sharing in digital pathology. Nat Commun. 2023 May 4;14(1):2577. doi: 10.1038/s41467-023-37991-y. (IF2022: 16,6; Q1)

Idkowiak J, Jirásko R, Kolářová D, Bártl J, Hájek T, Antonelli M, Vaňková Z, Wolrab D, Hrstka R, Študentová H, Melichar B, Pešková K, Holčapek M. Robust and high-throughput lipidomic quantitation of human blood samples using flow injection analysis with tandem mass spectrometry for clinical use. Anal Bioanal Chem. 2023 Feb;415(5):935-951. doi: 10.1007/s00216-022-04490-w. (IF2022: 4,3; Q1)

Kral J, Jelinkova S, Zemankova P, Vocka M, Borecka M, Cerna L, Cerna M, Dostalek L, Duskova P, Foretova L, Havranek O, Horackova K, Hovhannisyan M, Chvojka S, Kalousova M, Kosarova M, Koudova M, Krutilkova V, Machackova E, Nehasil P, Novotny J, Otahalova B, Puchmajerova A, Safarikova M, Slama J, Stranecky V, Subrt I, Tavandzis S, Zikan M, Zima T, Soukupova J, Kleiblova P, Kleibl Z, Janatova M. Germline multigene panel testing of patients with endometrial cancer. Oncol Lett. 2023 Apr 12;25(6):216. doi: 10.3892/ol.2023.13802. (IF2022: 2,9; Q3)

Moráňová L, Bartošík M, Strmisková J, Nováková K. Elektrochemická analýza klinických vzorků – cesta k translačnímu výzkumu. Chem. Listy 2023;117(10):595-603. doi: 10.54779/chl20230595. (IF2022: 0,6; Q4)

Ondraskova K, Sebuyoya R, Moranova L, Holcakova J, Vonka P, Hrstka R, Bartosik M. Electrochemical biosensors for analysis of DNA point mutations in cancer research. Anal Bioanal Chem. 2023 Mar;415(6):1065-1085. doi: 10.1007/s00216-022-04388-7. (IF2022: 4,3; Q1)

Sebuyoya R, Valverde A, Moranova L, Strmiskova J, Hrstka R, Ruiz-Valdepeñas Montiel V, Pingarrón JM, Barderas R, Campuzano S, Bartosik M. Dual detection system for cancer-associated point mutations assisted by a multiplexed LNA-based amperometric bioplatform coupled with rolling circle amplification. Sens Actuators B Chem. 2023; 394:134375. doi: 10.1016/j.snb.2023.134375. (IF2022: 8,4; Q1)

Vonka P, Rarova L, Bazgier V, Tichy V, Kolarova T, Holcakova J, Berka K, Kvasnica M, Oklestkova J, Kudova E, Strnad M, Hrstka R. Small change - big consequence: The impact of C15-C16 double bond in a D‑ring of estrone on estrogen receptor activity. J Steroid Biochem Mol Biol. 2023 Oct;233:106365. doi: 10.1016/j.jsbmb.2023.106365. (IF2022: 4,1; Q2)

Bouchalova P, Sommerova L, Potesil D, Martisova A, Lapcik P, Koci V, Scherl A, Vonka P, Planas-Iglesias J, Chevet E, Bouchal P, Hrstka R. Characterization of the AGR2 interactome uncovers new players of Protein Disulfide Isomerase network in cancer cells. Mol Cell Proteomics 2022:21(2):100188. doi: 10.1016/j.mcpro.2021.100188. (IF2021: 7,381; Q1)

Burkoň P, Trna J, Slávik M, Němeček R, Kazda T, Pospíšil P, Dastych M, Eid M, Novotný I, Procházka T, Vrzal M. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration. Biomedicines. 2022 Oct 4;10(10):2480. doi: 10.3390/biomedicines10102480. (IF2021: 4,757; Q2)

Brázdil T, Gallo M, Nenutil R, Kubanda A, Toufar M, Holub P. Automated annotations of epithelial cells and stroma in hematoxylin-eosin-stained whole-slide images using cytokeratin re-staining. J Pathol Clin Res. 2022 Mar;8(2):129-142. doi: 10.1002/cjp2.249. (IF2021: 4,373; Q1)

Halámková J, Bohovicová L, Pehalová L, Goněc R, Staněk T, Kazda T, Mouková L, Krákorová DA, Kozáková Š, Svoboda M, Demlová R, Kiss I. Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients. Cancers (Basel). 2022 Mar 27;14(7):1699. doi: 10.3390/cancers14071699. (IF2021: 6,575; Q1)

Holanek M, Selingerova I, Fabian P, Coufal O, Zapletal O, Petrakova K, Kazda T, Hrstka R, Poprach A, Zvarikova M, Bilek O, Svoboda M. Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy. Diagnostics (Basel). 2022 Jul 18;12(7):1740. doi: 10.3390/diagnostics12071740. (IF2021: 3,992; Q1)

Moranova L, Stanik M, Hrstka R, Campuzano S, Bartosik M. Electrochemical LAMP-based assay for detection of RNA biomarkers in prostate cancer. Talanta 2022; 238(Part 2):123064. doi: 10.1016/j.talanta.2021.123064. (IF2021: 6,556; Q1)

Obermannova R, Selingerova I, Rehak Z, Jedlicka V, Slavik M, Fabian P, Novotny I, Zemanova M, Studentova H, Grell P, Zdrazilova Dubska L, Demlova R, Harustiak T, Hejnova R, Kiss I, Vyzula R. PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study. Ther Adv Med Oncol. 2022 Jan 5;13:17588359211065153. doi: 10.1177/17588359211065153. (IF2021: 8,168; Q1)

Rihacek M, Selingerova I, Kocak I, Kocakova I, Rihackova E, Valik D, Sterba J. Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer Patients. Curr Oncol. 2022 Jun 7;29(6):4138-4147. doi: 10.3390/curroncol29060330. (IF2021: 3,109; Q3)

Sebuyoya R, Moranova L, Izadi N, Moran L, Hrstka R, Anton M, Bartosik M. Electrochemical DNA biosensor coupled to LAMP reaction for early diagnostics of cervical precancerous lesions. Biosens Bioelectron X 2022;12:100224. doi: 10.1016/j.biosx.2022.100224. (bez IF; Q1)

Wolrab D, Jirásko R, Cífková E, Höring M, Mei D, Chocholoušková M, Peterka O, Idkowiak J, Hrnčiarová T, Kuchař L, Ahrends R, Brumarová R, Friedecký D, Vivo-Truyols G, Škrha P, Škrha J, Kučera R, Melichar B, Liebisch G, Burkhardt R, Wenk MR, Cazenave-Gassiot A, Karásek P, Novotný I, Greplová K, Hrstka R, Holčapek M. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat Commun. 2022 Jan 10;13(1):124. doi: 10.1038/s41467-021-27765-9. (IF2021: 17,694; Q1)

Galoczova, M., Nenutil, R., Pokorna, Z., Vojtesek, B., Coates, P. J. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis. Virchows Arch 2021;478(4):627-636. doi: 10.1007/s00428-020-02944-z. (IF2020: 4,064; Q2)

Halamkova, J., Kazda, T., Pehalova, L., Gonec, R., Kozakova, S., Bohovicova, L., Adamkova Krakorova, D., Slaby, O., Demlova, R., Svoboda, M., Kiss, I. Second primary malignancies in colorectal cancer patients. Sci Rep 2021;11(1):2759. doi: 10.1038/s41598-021-82248-7. (IF2020: 4,380; Q1)

Halamkova, J., Kazda, T., Pehalova, L., Gonec, R., Kozakova, S., Bohovicova, L., Slaby, O., Demlova, R., Svoboda, M., Kiss, I. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients. Front Oncol 2021;10:573394. doi: 10.3389/fonc.2020.573394. (IF2020: 6,244; Q2)

Holanek, M., Selingerova, I., Bilek, O., Kazda, T., Fabian, P., Foretova, L., Zvarikova, M., Obermannova, R., Kolouskova, I., Coufal, O., Petrakova, K., Svoboda, M., Poprach, A. Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence. Cancers (Basel) 2021;13(7):1586. doi: 10.3390/cancers13071586.  (IF2020: 6,639; Q1)

Holcakova, J., Bartosik, M., Anton, M., Minar, L., Hausnerova, J., Bednarikova, M., Weinberger, V., Hrstka, R. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers. Cancers (Basel). 2021 Dec 17;13(24):6339. doi: 10.3390/cancers13246339. (IF2020: 6,639; Q1)

Izadi, N., Sebuyoya, R., Moranova, L., Hrstka, R., Anton, M., Bartosik, M. Electrochemical bioassay coupled to LAMP reaction for determination of high-risk HPV infection in crude lysates. Anal Chim Acta. 2021 Dec 1;1187:339145. doi: 10.1016/j.aca.2021.339145. (IF2020: 6,558; Q1)

Selingerova, I., Valik, D., Gescheidtova, L., Sramek, V., Cermakova, Z., Zdrazilova-Dubska, L. Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI. J Med Virol 2021;93(3):1805-1809. doi: 10.1002/jmv.26612. (IF2020: 2,327; Q4) 

Selingerova, I., Katina, S., Horova, I. Comparison of parametric and semiparametric survival regression models with kernel estimation. J Stat Comput Sim 2021;91(13):2717-2739. doi: 10.1080/00949655.2021.1906875. (IF2020: 1,424; Q4)

Slavik, M., Burkon, P., Selingerova, I., Krupa, P., Kazda, T., Stankova, J., Nikl, T., Hejnova, R., Rehak, Z., Osmera, P., Prochazka, T., Dvorakova, E., Pospisil, P., Grell, P., Slampa, P., Obermannova, R. Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET/CT: Results of Virtual Planning Study. Medicina (Lithuania Kaunas). 2021 Dec 6;57(12):1334. doi: 10.3390/medicina57121334. (IF2020: 2,430; Q2)

Zwinsová, B., Petrov, V. A., Hrivňáková, M., Smatana, S., Micenková, L., Kazdová, N., Popovici, V., Hrstka, R., Šefr, R., Bencsiková, B., Zdražilová-Dubská, L., Brychtová, V., Nenutil, R., Vídeňská, P., Budinská, E. Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour Progression. Cancers (Basel) 2021;13(19):4799. doi: 10.3390/cancers13194799. (IF2020: 6,639; Q1)

Holub, P., Kozera, L., Florindi, F., Van Enckevort, E., Swert, M., Reihs, R., Wutte, A., Valík, D., Mayrhofer, M. T. BBMRI-ERIC COMMUNITY, BBMRI-ERIC's Contributions to Research and Knowledge Exchange on COVID-19. Eur J Hum Genet 2020;28(6):728-731. doi: 10.1038/s41431-020-0634-8. (IF2019: 3,540; Q1)

Kýr, M., Klement, G. L., Zdrazilova-Dubska, L., Demlova, R., Valik, D., Slaby, O., Slavc, I., Sterba, J. Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize. Front Oncol 2020;10:377. doi: 10.3389/fonc.2020.00377. (IF2019: 4,250; Q1)

Liu, Y., Nekulova, M., Nenutil, R., Horakova, I., Appleyard, M. V., Murray, K., Holcakova, J., Galoczova, M., Quinlan, P., Jordan, L. B., Purdie, C. A., Vojtesek, B., Thompson, A. M., Coates, P. J. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER+ and HER2+ breast cancers. J Pathol Clin Res 2020;6(1):83-93. doi: 10.1002/cjp2.149. (IF2019: 3,489; Q4)

Náležinská, M., Zdražilová Dubská, L., Valík, D., Hernychová, L., Pavlík, T., Mazalová, M., Chovanec, J., Fait, V. Úskalí laboratorních metod v ovariálním skríninku - doba "-omická"? Onkologie 2020;14(2):88-92. doi: 10.36290/xon.2020.016. (bez IF)

Silvestri, V., Foretova, L., Machackova, E.  et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). JAMA Oncol 2020;6(8):1218-1230. doi: 10.1001/jamaoncol.2020.2134. (IF2019: 13,860; Q1)

Vyskočil, J. Kardiotoxicita onkologické léčby. Postgrad Med 2020;22(2):151-157. (bez IF)